Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous glucose monitor maker’s facilities last year. In a filing with the ...
Dexcom received a warning letter on March 4 after the Food and Drug Administration found problems at facilities in Arizona and California, the company revealed Friday in a securities filing. Dexcom ...
The warning letter identified issues in manufacturing processes and quality management system at Dexcom’s facilities in San Diego, California and Mesa, Arizona. The company did not provide details ...
And we launched some products. Really important to know we launched DexCom ONE+. It's a product that's predominantly international at this point. It was really addressed to fit the needs of ...
Mark wears the Dexcom ONE+ Continuous Glucose Monitor that helps him track his glucose levels to manage his Type 2 diabetes. For more information, visit Dexcom.com ...
Mark wears the Dexcom ONE+ Continuous Glucose Monitor that helps him track his glucose levels to manage his Type 2 diabetes. For more information, visit Dexcom.com ...
Mark wears the Dexcom ONE+ Continuous Glucose Monitor that helps him track his glucose levels to manage his Type 2 diabetes. For more information, visit Dexcom.com ...
(COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in Southern Colorado frustrated. A Dexcom is responsible for ...
During its latest quarter, DexCom secured reimbursement for its Dexcom ONE+ in France for people with Type II Diabetes, helping to significantly expand access in the French market. The company also ...
The “Dexcom State of Type 2 Report,” released in conjunction with the launch of the Dexcom ONE+ continuous glucose monitor, also found: 63% of people with diabetes are encountering difficulties in ...
The year-over-year revenue growth was driven by strong new patient performance and the expanded availability of its G7 and DexCom ONE+ product platforms. Following the earnings release ...